Preclinical gene editing biotech developing therapies for rare diseases.
Industry: Health Care
First Day Return: +15.0%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/25/2018 |
Offer Price | $10.00 |
Price Range $12.00 - $14.00 | |
Offer Shares (mm) | 7.0 |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 10/18/2018 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Cambridge, MA, United States |
Founded | 2014 |
Employees at IPO | 20 |
Website www.logicbio.com |